AQST

AQST Operating Cash Flow (Statement)

-$45.37MTTM · USD

Period ending:

AQST FY Cash from OperationsUSD
AQST FY Cash from Operations2016-12-31: -$8.18M2017-12-31: $5.82M2018-12-31: -$12.99M2019-12-31: -$60.21M2020-12-31: -$45.46M2021-12-31: -$32.98M2022-12-31: -$9.79M2023-12-31: -$6.38M2024-12-31: -$35.76M2025-12-31: -$52.43M$5.82M-$60.21M
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AQST operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Aquestive Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-52,432,000
-35,759,000
-6,380,000
-9,789,000
-32,979,000
-45,459,000
-60,210,000
-12,991,000
5,824,000
-8,175,000

Compare operating cash flow (statement)

All AQST financial metrics · AQST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.